Your money goes towards helping the clinical research work of highly valued research institutions. There is a surprising lack of funding for childhood cancers like rhabdomyosarcoma which has meant the opportunity to research the biology and develop new treatment options is not nearly as advanced as some adult cancers. The survival rate remains largely unchanged over the last 30 years with chemotherapy drugs that are decades old being used. We urgently need this to change. These children deserve a better chance to live a long and fulfilled life.